CEWG Steering Committee
Laura M. Heiser, PhD
(2025-2027)Associate Professor and Vice Chair
Department of Biomedical Engineering
Co-Leader, Knight Cancer Institute Quantitative Oncology Program
Associate Director, Complex Systems Modeling, Cancer Early Detection Advanced Research
Oregon Health & Science University
Portland, Oregon
Samuel Aparicio, BM, BCh, PhD, FRCPath, FRSC
(2026-2029)Professor, Department of Pathology and Laboratory Medicine
University of British Columbia;
Canada Research Chair in Molecular Oncology;
Nan & Lorraine Robertson Chair of Breast Cancer Research, UBC/BC Cancer;
Associate Member, University of British Columbia, CIHR/MSFHR Bioinformatics Program;
Associate Member, BC Cancer, Genome Sciences Center;
Affiliated Investigator, Vancouver Coastal Health Authority;
Distinguished Scientist, Department of Molecular Oncology, BC Cancer
Vancouver, British Columbia, Canada
Antonio Baines, PhD
(2024-2027)Associate Professor
Department of Biological & Biomedical Sciences
Cancer Research Program
JLC-Biomedical/Biotechnology Research Institute
Adjunct Associate Professor
Department of Pharmacology
School of Medicine
Member
Curriculum in Toxicology and Environmental Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Yin Cao, ScD, MPH
(2026-2029)Associate Professor of Surgery
Associate Professor of Medicine
Washington University School of Medicine in St. Louis
St. Louis, Missouri
Giulio Caravagna, PhD
(2026-2029)Trieste, Italy
Nic Fisk, PhD
(2025-2028)Assistant Professor
Computational Biology/DBER
University of Rhode Island
Kingston, Rhode Island
Gad Getz, PhD, FAACR
(2024-2027)Director
Cancer Genome Analysis
The Broad Institute of MIT and Harvard
Krantz Family Center for Cancer Research
Department of Pathology
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Trevor Graham, PhD, FMedSci
(2025-2028)Director, Centre for Evolution and Cancer
Institute of Cancer Research
London, United Kingdom
Laurie Graves, MD
(2026-2029)Durham, North Carolina
Benjamin Greenbaum, PhD
(2026-2029)Director, Computational Immuno-Oncology
Attending Computational Oncologist
Computational Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York
Jinsong Liu, MD, PhD
(2024-2027)Professor
Departments of Anatomic Pathology and Molecular Cellular Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas
Paul S. Mischel MD, FAACR
(2025-2028)Fortinet Founders Professor
Professor, By Courtesy, Department of Neurosurgery
Vice Chair for Research, Department of Pathology
Institute Scholar and Deputy Director, Translational Science, Sarafan ChEM-H
Stanford University
Stanford, California
Eileen M. O’Reilly, MD
(2024-2027)Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head
Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-director Medical Initiatives
David M. Rubenstein Center for Pancreatic Cancer
Chair
Human Research Protection Program & IRB
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York
Laura Rosenberg, PhD
(2025-2028)Director, Discovery Sciences Target Validation
AstraZeneca, BioPharmaceuticals R&D
Cambridge, United Kingdom
Mariangela Russo, PhD
(2025-2028)Associate Professor
Department of Oncology
University of Turin
Turin, Italy
Louis Vermeulen, MD, PhD
(2024-2027)Vice President
Discovery Oncology
Genentech Inc.
Professor of Molecular Oncology
LEXOR Department
Amsterdam UMC Cancer Center
Amsterdam, The Netherlands